Advertisement

Advertisement

CERO Stock Latest News

CERo Therapeutics Raises Capital via Convertible Note Financing

Company AnnouncementsCERo Therapeutics Raises Capital via Convertible Note Financing

CERo Therapeutics Secures Convertible Note Financing Facility

PremiumCompany Announcements

CERo Therapeutics Secures Convertible Note Financing Facility

1M ago

CERo Therapeutics Delays 2025 Annual Report Filing

PremiumCompany Announcements

CERo Therapeutics Delays 2025 Annual Report Filing

2M ago

Cero Therapeutics issues letter to shareholders

PremiumThe Fly

Cero Therapeutics issues letter to shareholders

2M ago

CERo Therapeutics Enters Convertible Note Financing Agreement

PremiumCompany Announcements

CERo Therapeutics Enters Convertible Note Financing Agreement

2M ago

Cero Therapeutics appoints Eric Francois to board of directors

PremiumThe FlyCero Therapeutics appoints Eric Francois to board of directors

3M ago

CERo Therapeutics Announces Convertible Note Financing and New Director

Company Announcements

CERo Therapeutics Announces Convertible Note Financing and New Director

3M ago

Cero Therapeutics to present data from Phase 2 trial of CER-1236

The Fly

Cero Therapeutics to present data from Phase 2 trial of CER-1236

4M ago

CERo Therapeutics Securities Delisted Following Nasdaq Appeal Denial

PremiumCompany Announcements

CERo Therapeutics Securities Delisted Following Nasdaq Appeal Denial

4M ago

CERo Therapeutics reports encouraging early CERTAINT-1 trial data

PremiumCompany Announcements

CERo Therapeutics reports encouraging early CERTAINT-1 trial data

4M ago

Cero Therapeutics provides update on Phase 1 trial of CER-1236

PremiumThe Fly

Cero Therapeutics provides update on Phase 1 trial of CER-1236

4M ago

CERo Therapeutics shareholders approve key capital structure changes

PremiumCompany Announcements

CERo Therapeutics shareholders approve key capital structure changes

5M ago

Cero Therapeutics provides update on Phase 1 trial of CER-1236

PremiumThe FlyCero Therapeutics provides update on Phase 1 trial of CER-1236

5M ago

CERo Therapeutics Enters New $14.6M Stock Agreement

Company Announcements

CERo Therapeutics Enters New $14.6M Stock Agreement

6M ago

Cero Therapeutics announces trading on OTCQB Market

The Fly

Cero Therapeutics announces trading on OTCQB Market

6M ago

Cero Therapeutics downgraded to Hold from Buy at D. Boral Capital

PremiumThe Fly

Cero Therapeutics downgraded to Hold from Buy at D. Boral Capital

6M ago

CERo Therapeutics Delays Quarterly Report Filing

PremiumCompany Announcements

CERo Therapeutics Delays Quarterly Report Filing

6M ago

Cero Therapeutics initiates second cohort in Phase 1 trial of CER-1236

PremiumThe Fly

Cero Therapeutics initiates second cohort in Phase 1 trial of CER-1236

7M ago

Cero Therapeutics to present data on CER-1236 at SITC conference

PremiumThe Fly

Cero Therapeutics to present data on CER-1236 at SITC conference

7M ago

Cero Therapeutics announces listing on OTC Markets

PremiumThe FlyCero Therapeutics announces listing on OTC Markets

7M ago

Cero Therapeutics downgraded to Hold from Buy at Maxim

The Fly

Cero Therapeutics downgraded to Hold from Buy at Maxim

7M ago

Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!

Market News

Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >